Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
297 participants
OBSERVATIONAL
2012-11-30
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Management of Spinal Cord Injuries In Neck
NCT00475748
Spinal Decompression Plus Nerve Graft Implantation Following TSCI
NCT06243211
Neurologic Complications in Spinal Deformity Surgery - Extension
NCT02949245
Efficacy of Spinal Cord Stimulation in Patients With a Failed Back Surgery Syndrome.
NCT03462147
Epidural Decompression Surgery Within 24 Hours After Acute Spinal Cord Injury Improves Spinal Nerve Function
NCT03103516
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a multi-center, prospective, observational cohort study to evaluate if early (≤ 12 hours after the tSCI) surgical decom¬pression is superior to late (\> 12 hours and \< 14 days after the tSCI) in improving neurologic motor outcomes in patients with acute traumatic spinal cord injury.
The study will enroll 300 patients with anticipated 1:2 ratio of early vs. late surgery. This CIP is not limited to cervical spinal cord injuries, does not consider a diagnostic MRI as mandatory and will be conducted in a European setting where patients are generally transported more swiftly to the treating institution when compared to other geographic regions in the world.
Patients will be evaluated according to the schedule set forth in this CIP. The schedule includes evaluations at pre-surgery, post-surgery, 72 hours post injury, 12 weeks ± 2 weeks; 6 months ± 30 days; 1 year ± 30 days. The enrollment period is expected to be approximately 36 months and subjects will be followed-up for 12 months for the evaluation of the primary endpoint. The study duration is approximately 48 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early surgical intervention = Cohort 1
≤ 12 hours after the tSCI
Early surgical intervention
Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation
Late surgical intervention = Cohort 2
\> 12 hours and \< 14 days after the tSCI
Late surgical intervention
Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early surgical intervention
Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation
Late surgical intervention
Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of blunt spinal column injury and spinal cord injury, including conus medullaris and/or cauda equina injuries
* Pre-surgery ASIA grade A, B, C or D
* Less than 14 days between the injury and surgery
* Ability to understand patient information / informed consent form
* Willingness and ability to participate in the clinical investigation and FU procedures (FUs)
* Informed consent according to local legislations and applicable guidelines
Exclusion Criteria
* Diagnosis of subclinical or clinical polyneuropathy (eg. presence of bilateral impairment of strength, sensation, and/or deep tendon reflexes with symmetrical and distal distribution and/or neurophysiological abnormalities)
* Spinal cord injury caused by a penetrating injury
* Non-traumatic or pathologic fractures or cord compression (eg, tumor or infection)
* Unable to cooperate with physical examination (pre-operative, ≤ 2 weeks) because of cognitive impairment, as assessed by the examiner
* Previous spinal column or spinal cord injury
* Diagnosis of spondyloarthropathy (inflammatory or non-inflammatory)
* Morbid Obesity: Body Mass Index (BMI) \> 35
* Any severe systemic disease that may have an influence on motor function (eg, polyneuropathy)
* ASA classification score ≥ 4
* Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
* Pregnancy at the time of inclusion
* Prisoner
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AOSpine Europe
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Allard JF Hosman, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Medical Co-Director Spine Unit, Radboud University Medical Centre, 6500 Nijmegen, The Netherlands
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University Innsbruck
Innsbruck, , Austria
National Institute of Emergency Medicine "N.I. Pirogov"
Sofia, , Bulgaria
Teaching Hospital Sisiters of Charity
Zagreb, , Croatia
Hôspital P. Wertheimer
Lyon, , France
BG Unfallklinik Frankfurt
Frankfurt, , Germany
Berufsgenossenschaftliche Unfallklinik Ludwigshafen
Ludwigshafen, , Germany
Mater Misericordiae University Hospital
Dublin, , Ireland
Ospedale Maggiore
Bologna, , Italy
Policlinico Umberto Primo
Rome, , Italy
University Medical Center St. Radboud
Nijmegen, , Netherlands
University Medical Center Utrecht
Utrecht, , Netherlands
Spitalul "Sfanta Treime"
Iași, , Romania
Clinical Center Vojvodina
Novi Sad, , Serbia
Gazi University Faculty of Medicine
Ankara, , Turkey (Türkiye)
King's College Hospital
London, , United Kingdom
Queens's Medical Centre Campus
Nottingham, , United Kingdom
Nuffield Orthopaedic Centre Headington
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCI-POEM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.